Skip to main content
JADPRO Live 2023 Main banner
Final Program


Conference Brochure
Icon Legend
Presentation Icons
CE credit available
CE credit available
Pharmacology credit available
Pharmacology credit available
Poster session
Poster session

Full Schedule

Full Schedule

  • Friday, November 10, 2023
  • 6:30 AM – 7:45 AM ET
    Breakfast Activity/Non-CE-Accredited Satellite Symposium
    Janssen Oncology invites you to learn more about a treatment for adult patients with RRMM who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody
    Janssen: Pharmaceutical Companies of Johnson & Johnson

    Seating available on first-come, first-served basis
  • 6:30 AM – 7:45 AM ET
    Breakfast Activity/Non-CE-Accredited Satellite Symposium: Exelixis Clinical Product Overview for Advanced Practice Providers
    Exelixis

    Seating available on first-come, first-served basis
  • 6:30 AM – 7:45 AM ET
    Breakfast Activity/Non-CE-Accredited Satellite Symposium: Supporting Patients With HR+/HER2- mBC Throughout Their Treatment Journey
    Pfizer Oncology

    Seating available on first-come, first served basis
  • 6:30 AM – 7:45 AM ET
    Breakfast Activity/Non-CE-Accredited Satellite Symposium: Treatment Options for Patients with Unresectable or Metastatic Melanoma​
    Bristol Myers Squibb

    Seating available on first-come, first-served basis
  • 6:30 AM – 6:00 PM ET
    Registration
  • 7:00 AM – 8:00 AM ET
    Exhibit Hall Open & Continental Breakfast
  • 8:00 AM – 8:10 AM ET
    Welcome & Opening Remarks
  • 8:10 AM – 9:15 AM ET
    Opening Panel Discussion
    Advanced Practitioners in Hematology and Oncology: A Call to Action
  • 9:30 AM – 10:15 AM ET
    Optimizing the Care of Patients with Colorectal Cancer in Clinical Practice
  • 9:30 AM – 10:15 AM ET
    The Evolving Landscape of Frontline Therapy in Chronic Lymphocytic Leukemia
  • 10:15 AM – 11:15 AM ET
    Exhibit Hall Open & Refreshment Break
  • 10:15 AM – 6:15 PM ET
    Braindate
  • 10:30 AM – 11:00 AM ET
    APSHO Committee Meet & Greet: Awards & Recognition Committee
  • 10:30 AM – 11:00 AM ET
    Exhibit Hall Presentation: An Advancement in Frontline DLBCL
    Genentech
  • 10:30 AM – 11:00 AM ET
    Exhibit Hall Presentation: Cosela: A Multilineage Myeloprotection Therapy
    G1 Therapeutics
  • 10:30 AM – 11:30 AM ET
    Exhibit Hall Presentation: Relapsed or Refractory Multiple Myeloma: A Case-based Presentation
    Sanofi
  • 11:15 AM – 12:15 PM ET
    Advancing Precision-Targeted Treatment for Patients with Metastatic Non-Small Cell Lung Cancer
  • 11:15 AM – 12:15 PM ET
    Cardio-Oncology Considerations in Patients With Cancer
  • 12:15 PM – 1:45 PM ET
    Exhibit Hall Open & Lunch
  • 12:15 PM – 1:45 PM ET
    Lunch Activity/Non-CE-Accredited Satellite Symposium: A Collaborative Approach to Deciding When to Intervene With Jakafi® (ruxolitinib) For Adults With Polycythemia Vera Who Have Had an Inadequate Response to Hydroxyurea
    Incyte

    Seating available on first-come, first served basis
  • 12:15 PM – 1:45 PM ET
    Lunch Activity/Non-CE-Accredited Satellite Symposium: PADCEV® (enfortumab vedotin-ejfv): Use as A Single Agent or In Combination With a PD⁠-⁠1 Inhibitor - 081-1005-PM
    Seagen

    Seating available on first-come, first-served basis
  • 12:15 PM – 1:45 PM ET
    Lunch Activity/Non-CE-Accredited Satellite Symposium: The Role of APPs in Maximizing Patient Outcomes with DARZALEX® and DARZALEX® FASPRO® +Rd in Patients with Newly Diagnosed, Transplant-Ineligible Multiple Myeloma.
    Janssen Oncology part of the Pharmaceutical Companies of Johnson & Johnson

    Seating available on first-come, first-served basis
  • 12:15 PM – 1:45 PM ET
    Lunch Activity/Non-CE-Accredited Satellite Symposium: Treatment Options for Patients with Resectable and Metastatic Non-Small Cell Lung Cancer​
    Bristol Myers Squibb

    Seating available on first-come, first-served basis
  • 12:30 PM – 1:00 PM ET
    APSHO Committee Meet & Greet: Communications Committee
  • 1:15 PM – 1:45 PM ET
    APSHO Committee Meet & Greet: Diversity, Equity, & Inclusion Committee (DEI)
  • 1:45 PM – 2:45 PM ET
    Keynote Address: We the Patients
  • 2:45 PM – 3:45 PM ET
    Exhibit Hall Open & Refreshment Break
  • 2:45 PM – 3:45 PM ET
    Moderated Posters: Clinical Posters, Industry Encore Posters, & APSHO Patient Perspective Posters
  • 3:00 PM – 3:30 PM ET
    APSHO Committee Meet & Greet: Education Committee
  • 3:00 PM – 3:30 PM ET
    Exhibit Hall Presentation
    Bispecific Antibodies in DLBCL: Navigating the Evolving Treatment Landscape
    AbbVie and Genmab
  • 3:00 PM – 3:30 PM ET
    Exhibit Hall Presentation: Diagnostic Approach and Considerations in Patients with Hemolytic Anemia
    Agios Pharmaceuticals
  • 3:00 PM – 3:30 PM ET
    Exhibit Hall Presentation: Explore the current data that could help you recognize/assess candidates for a CDK4 & 6 inhibitor.
    Eli Lilly and Company
  • 3:45 PM – 4:30 PM ET
    Individualizing Care for Multiple Myeloma: Navigating Treatment Options and Addressing Patient Needs
  • 3:45 PM – 4:30 PM ET
    Unveiling the Impact of Radiation Therapy: Navigating Acute and Long-Term Side Effects for Optimal Patient Care
  • 3:45 PM – 4:45 PM ET
    Oral Poster Presentations
  • 4:45 PM – 5:30 PM ET
    Independent Certified Satellite Symposium Targeted Therapy Approaches for Metastatic Urothelial Carcinoma
  • 5:30 PM – 6:15 PM ET
    Independent Certified Satellite Symposium Treatment Advances with Novel Anti-Androgen Therapy, PARP Inhibitors, and NGI For Hormone-Sensitive and Castration-Resistant Prostate Cancer
  • 6:15 PM – 8:15 PM ET
    Independent CE-Accredited Dinner Satellite Symposium
    Advancing the Myelofibrosis Treatment Paradigm: A Case-Based Collaborative for the Advanced Practitioner in Oncology